Article info

Download PDFPDF
Palivizumab for children with Down syndrome: is the time right for a universal recommendation?

Authors

  1. Correspondence to Dr Bosco Paes, Department of Pediatrics (Neonatal Division), McMaster University, Hamilton L8S 4K1, Canada; paes{at}mcmaster.ca
View Full Text

Citation

Paes B, Mitra S
Palivizumab for children with Down syndrome: is the time right for a universal recommendation?

Publication history

  • Received October 24, 2018
  • Revised December 11, 2018
  • Accepted December 12, 2018
  • First published December 27, 2018.
Online issue publication 
July 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.